Gastrointestinal Endoscopy
Volume 71, Issue 6 , Pages 927-933 , May 2010

Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients

Received 25 February 2009 ,Accepted 25 June 2009.

References 

  1. Flegal KM. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav. 2005;86:599–602
  2. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549–1555
  3. Weintaub M. Long-term weight control: the National Heart, Lung, Blood Institute funded multimodal intervention study. Clin Pharmacol. 1992;51(Suppl):581–646
  4. Rucker D, Padwal R, Li SK, et al. Long term pharmacotherapy for obesity and overweight: update and meta-analysis. Br Med J. 2007;335:1194–1199
  5. Steinbrook R. Surgery for severe obesity. N Engl J Med. 2004;350:1075–1079
  6. Sjöström MD, Narbro K, David C, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–752
  7. National Institute of Health Conference. Gastrointestinal surgery for severe obesity. Consensus development conference panel. Ann Intern Med. 1991;115:956–961
  8. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19–27
  9. Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–846
  10. Adams RJ, Appleton S, Wilson DH, et al. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care. 2005;28:2777–2779
  11. Palmentieri B, de Sio I, La Mura V, et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis. 2006;38:485–489
  12. Sanford NL, Walsh P, Matis C, et al. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease?. Gastroenterology. 1985;89:186–191
  13. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J. 1986;292:13–15
  14. Ammar K, Kors J, Yawn B, et al. Defining unrecognized myocardial infarction: a call for standardized electrocardiographic diagnostic criteria. Am Heart J. 2006;148:277–284
  15. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403
  16. Fernandes M, Atallah AN, Soares BGO, et al. Intragastric ballon for obesity. Cochrane Database Syst Rev. 2007;24(1):CD004931
  17. Norris SL, Zhang X, Avenell A, et al. Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med. 2004;117:762–774
  18. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2:367–373
  19. Sharma AM. The value of current interventions for obesity. Nat Clin Pract Cardiovasc Med. 2008;5(Suppl 1):S3–S29
  20. Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed?. Obes Surg. 2005;15:864–870

 DISCLOSURE: The authors disclosed no financial relationships relevant to this publication.

PII: S0016-5107(09)02193-2

doi: 10.1016/j.gie.2009.06.036

Gastrointestinal Endoscopy
Volume 71, Issue 6 , Pages 927-933 , May 2010

Article Tools

* Image Usage & Resolution